HK · Healthcare

China Shineway Pharmaceutical Group Ltd (2877)

Drug Manufacturers - Specialty & Generic

China Shineway Pharmaceutical Group Ltd (2877) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $6.38B, P/E ratio is 5.82, net margin is 30.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 2877

Market cap
$6.38B
P/E ratio
5.82
Gross profit (TTM)
$2.27B
Net margin
30.3%

China Shineway Pharmaceutical Group Ltd (2877) — FAQ

What is China Shineway Pharmaceutical Group Ltd's market cap?

China Shineway Pharmaceutical Group Ltd (2877) has a reported market cap of $6.38B (data as of 2026-05-21).

What is 2877's P/E ratio?

The price-to-earnings (P/E) ratio for China Shineway Pharmaceutical Group Ltd (2877) is 5.82 (data as of 2026-05-21).

Does China Shineway Pharmaceutical Group Ltd pay a dividend?

Dividend yield is not available in the current snapshot for China Shineway Pharmaceutical Group Ltd (2877). Check the MyAverix Finance app for the latest dividend data.

What sector is China Shineway Pharmaceutical Group Ltd in?

China Shineway Pharmaceutical Group Ltd (2877) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 2877 listed on?

2877 is listed on HK.

What is China Shineway Pharmaceutical Group Ltd's net margin?

China Shineway Pharmaceutical Group Ltd (2877) reports a net margin of 30.3% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play